A. De Nicolo

发表

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.

Z. Szallasi, E. Winer, A. Eklund, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

X chromosomal abnormalities in basal-like human breast cancer.

Shridar Ganesan, Xin Lu, Myles Brown, 2006, Cancer cell.

Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation

M. Federico, P. Radice, S. Manoukian, 2003, Breast Cancer Research and Treatment.

Combining common genetic variants and non‐genetic risk factors to predict risk of cutaneous melanoma

X. Hua, Jianxin Shi, S. Puig, 2018, Human molecular genetics.

Hepatosplenic γδ T‐cell lymphoma presenting with immune‐mediated thrombocytopenia and hemolytic anemia (Evans' syndrome)

G. Altavilla, A. Girolami, S. Agata, 2002 .

Identification of BRCA1 and BRCA2 carriers by allele‐specific gene expression (AGE) analysis

L. Chieco‐Bianchi, M. Montagna, S. Agata, 2002, International journal of cancer.

MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M‐SKIP project

S. Puig, H. Nan, J. Little, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

The BRCA2 sequence variant IVS19+1G-->A leads to an aberrant transcript lacking exon 19.

L. Chieco‐Bianchi, M. Montagna, S. Agata, 2003, Cancer genetics and cytogenetics.

Assays to Study Mitotic Centrosome and Spindle Pole Assembly and Regulation.

J. Walter, A. De Nicolo, V. Joukov, 2016, Methods in molecular biology.

Centrosomal protein of 192 kDa (Cep192) promotes centrosome-driven spindle assembly by engaging in organelle-specific Aurora A activation

D. Livingston, J. Walter, A. De Nicolo, 2010, Proceedings of the National Academy of Sciences.

Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).

G. Altavilla, A. Girolami, S. Agata, 2002, American journal of hematology.

Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.

G. Banna, L. Chieco‐Bianchi, M. Montagna, 2001, Cancer letters.

TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients

A. Vecchiato, A. De Nicolo, P. Del Bianco, 2020, Cancers.

MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium

S. Puig, M. Tucker, K. Peris, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility

Blair H. Smith, Jeffrey E. Lee, G. Abecasis, 2020, Nature Genetics.

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

Katherine M. Tucker, Sebastian A. Wagner, Kelly J. Sullivan, 2019, Human Mutation.

Aurora-PLK1 cascades as key signaling modules in the regulation of mitosis

A. De Nicolo, V. Joukov, 2018, Science Signaling.

The Cep192-organized aurora A-Plk1 cascade is essential for centrosome cycle and bipolar spindle assembly.

J. Walter, A. De Nicolo, V. Joukov, 2014, Molecular cell.

Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility

Blair H. Smith, Jeffrey E. Lee, G. Abecasis, 2020, Nature Genetics.

The Centrosome and the Primary Cilium: The Yin and Yang of a Hybrid Organelle

A. De Nicolo, V. Joukov, 2019, Cells.

Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.

L. Chieco‐Bianchi, M. Montagna, S. Agata, 2003, Human molecular genetics.

A Novel Breast Cancer–Associated BRIP1 (FANCJ/BACH1) Germ-line Mutation Impairs Protein Stability and Function

B. Sobhian, R. Drapkin, G. Bevilacqua, 2008, Clinical Cancer Research.

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.

F. Couch, O. Olopade, R. Eeles, 2018, JCO precision oncology.

BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.

G. Banna, S. Monfardini, A. De Nicolo, 2001, Cancer treatment reviews.

BRAF Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors

S. Mocellin, V. Chiarion-Sileni, M. Montesco, 2018, Molecular Cancer Therapeutics.

Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.

M. Vidal, M. Cusick, Q. Zhong, 2009, Cancer research.

Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy

B. Bonanni, G. Matullo, P. Radice, 2021, Cancers.

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

James M. Hodge, E. Burnside, Y. Kamatani, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.